Physical examination revealed a large, confluent, and bright red lichenified plaque with linear excoriations ... of vaginal candidiasis, seborrheic dermatitis, and tinea pedis.
In this self-controlled, prospective trial sponsored by the manufacturer of the PDL, 22 patients with plaque psoriasis received four different treatment options, one each to one of four similar ...
Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system.
The American Academy of Dermatology is the largest, most influential, and representative dermatology group in the United States. Find resources on membership, AAD meetings, education, practice ...
J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...
PNP combines clinical and histologic features of PV and lichenoid/interface dermatitis, reflecting a mixed B- and T-cell response against epidermal autoantigens. Indeed, while declining B-cells ...